98%
921
2 minutes
20
Purpose: To assess if 1PN-derived embryos are diploid/euploid and suitable for embryo transfer.
Methods: This systematic review and meta-analysis were conducted according to the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. PubMed, Embase, and SCOPUS were systematically searched for peer-reviewed original papers using relevant keywords and Medical Subject Heading (MeSH) terms: "1PN" OR "monopronucleated" OR "single pronucleus" AND "cleavage" OR "embryo quality" OR "blastocyst quality" OR "blastulation" OR "embryo development" OR "euploidy" OR "ploidy" OR "pregnancy" OR "live birth" OR "miscarriage" OR "clinical outcomes" OR "malformation."
Results: A total of 21 studies met the inclusion criteria. Compared to 2PN-derived embryos, 1PN-derived embryos exhibited a lower blastulation rate and clinical outcomes when transferred without prior genetic testing. However, 1PN-derived embryos demonstrated similar euploidy and live birth rates following euploid blastocyst transfer, as well as comparable malformation rates to their 2PN counterparts. A non-significant trend toward a higher risk of abnormal ploidy constitution was observed in 1PN-derived embryos. Notably, pregnancy and live birth rates were significantly lower for 1PN-derived embryos from ICSI compared to those from conventional IVF.
Conclusions: 1PN-derived embryos, though less competent than 2PNs, can lead to healthy live births. They may be cautiously utilized in clinical practice, particularly when biparental diploidy has been confirmed.
Clinical Trial Registration: CRD42024605305.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10815-025-03631-1 | DOI Listing |
J Assist Reprod Genet
August 2025
Obstetrics and Gynaecology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Purpose: To assess if 1PN-derived embryos are diploid/euploid and suitable for embryo transfer.
Methods: This systematic review and meta-analysis were conducted according to the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. PubMed, Embase, and SCOPUS were systematically searched for peer-reviewed original papers using relevant keywords and Medical Subject Heading (MeSH) terms: "1PN" OR "monopronucleated" OR "single pronucleus" AND "cleavage" OR "embryo quality" OR "blastocyst quality" OR "blastulation" OR "embryo development" OR "euploidy" OR "ploidy" OR "pregnancy" OR "live birth" OR "miscarriage" OR "clinical outcomes" OR "malformation.
BMC Pregnancy Childbirth
May 2025
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Cheeloo College of Medicine, Institute of Women, Children and Reproductive Health, Shandong University, 157 Jingliu Road, Jinan, 250012, Shandong, China.
Background: While zygotes lacking pronuclei (0PN) or exhibiting a single pronucleus (1PN) may theoretically yield diploid embryos with developmental potential, current clinical protocols predominantly exclude these embryos from use. In the population undergoing preimplantation genetic testing for structural rearrangements (PGT-SR), there is a high rate of chromosomal aneuploidy abnormalities and needs a large number of embryos to obtain euploid embryos, so we will explore whether 0PN and 1PN embryos can be an option for them.
Methods: This retrospective analysis examined pronuclear development in 4,868 zygotes derived from 4,902 injected metaphase II (MII) oocytes across 422 assisted reproductive cycles.
J Assist Reprod Genet
December 2024
Igenomix Spain Lab S.L.U., Research and Development, Paterna, Spain.
Purpose: We aimed to identify the correlation between morphological pronuclear (PN) status and the genetically determined ploidy configuration in preimplantation embryos.
Methods: A retrospective observational study was conducted on 1982 embryos displaying normal fertilization and 380 embryos showing an atypical PN pattern, tested for aneuploidies and ploidy status via preimplantation genetic testing (PGT) between May 2019 and May 2024. Ploidy prediction was performed using a validated targeted-NGS approach and a proprietary bioinformatic pipeline analyzing SNPs B-allele frequency information.
Medicina (Kaunas)
August 2024
Center for Reproductive Medicine, University of Liège, Boulevard du 12ème de Ligne 1, 4000 Liege, Belgium.
Fertil Steril
October 2024
Department of Obstetrics and Gynecology, IVF Unit, Chaim Sheba Medical Center, Tel- Hashomer, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Objective: To study and compare the preimplantation genetic testing for monogenic disorders (PGT-M) results, and to evaluate the treatment cycle outcomes of embryos derived from a single pronucleus (1PN) vs. two pronuclei (2PN).
Design: A retrospective cohort study from January 2018 to December 2022 involving in vitro fertilization (IVF)-PGT-M treatment cycles.